Management of persons with high risk of coronary heart disease but low serum low-density lipoprotein cholesterol - 28/08/11
Doi : 10.1016/S0002-9149(03)00167-X
Christopher C. Case, MD a, Terry A. Jacobson, MD b, Susan Roberts, PhD c, Ann Buckley, MPH c, Kathleen M. Murtaugh, BS d, Jennifer C.Y. Sung, PharmD e, Douglas Gause, DrPH e, Cristina Varas, MD f, Christie M. Ballantyne, MD a, ⁎ 
a Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
b Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
c PPD Development, Wilmington, North Carolina, USA
d Reliant Pharmaceuticals, LLC, Liberty Corner, New Jersey, USA
e Novartis Health Economics and Outcomes Research, East Hanover, New Jersey, USA
f Novartis Global Epidemiology, Barcelona, SpainThis study was supported by a nonrestricted educational grant from Reliant Pharmaceuticals, LLC, Liberty Corner, New Jersey.
*Dr. Ballantyne’s address is: Center for Cardiovascular Disease Prevention, Baylor College of Medicine, 6565 Fannin, MS A-601 Houston, Texas 77030, USA.
© 2003
Excerpta Medica Inc. Tous droits réservés.
Vol 91 - N° 9
P. 1134-1136 - mai 2003 Retour au numéro
Article précédent
- Evaluation by electron beam tomography of changes in calcified coronary plaque in treated and untreated asymptomatic patients and relation to serum lipid levels
- Harvey S Hecht, S.Mitchell Harman
- Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery
- Jennifer Zimmer, John Pezzullo, Wassim Choucair, Jeffrey Southard, Peter Kokkinos, Pamela Karasik, Michael D. Greenberg, Steven N. Singh
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?